As a biomarker for neonatal bacterial infections, Park et al. have reported that when a cut-off value of 0.5 ng/mL for PCT was used for diagnosing neonatal late-onset bacterial infections, the sensitivity and specificity were 88% and 58%, respectively [14], which are insufficient for clinical applicability. This evidence concerns the gene CALCA and bacterial infectious disease.